Rail Merger Threatens Economy

PFAS Stewardship and Regulation

Two Supervisors reviewing Plans with Facility in Background

Industry Leadership in PFAS Stewardship and Regulatory Collaboration

Most of the attention on PFAS has focused on a handful of legacy substances—such as PFOA and PFOS—which are no longer manufactured in the U.S., Europe, or Japan. In the U.S., major manufacturers voluntarily phased out manufacture of these substances beginning in the early 2000s.  

As a result, blood levels of legacy PFAS have declined dramatically, according to CDC data. In their place, industry has developed new short-chain PFAS chemistries, which:

  • Have been thoroughly reviewed under EPA’s TSCA New Chemicals Program
  • Are supported by robust health and safety data

Guidance & Emissions Reduction

Manufacturers and users of modern PFAS are implementing technologies and practices to minimize environmental emissions. ACC has developed guidance documents for sectors such as:

  • Textiles
  • Firefighting foams
  • Medical and industrial applications

These efforts reflect a commitment to continuous improvement and environmental responsibility.

Regulatory Engagement

ACC supports a comprehensive regulatory framework that includes:

  • Prioritization of PFAS based on risk
  • Management of priority substances
  • Remediation of impacted sites
  • Tracking and evaluation of regulatory effectiveness

 

ACC works closely with policymakers to support:

  • Science-based chemical reviews
  • Expanded Significant New Use Rules to prevent reintroduction of phased-out PFAS
  • Data collection and transparency through EPA’s PFAS Strategic Roadmap

Supporting Resources